Sincerus Pharmaceuticals Completes Financing With SWK To Support The Demand For Its Customized Dermatologic Medicines

POMPANO BEACH, Fla., March 24, 2021 /PRNewswire/ — Sincerus Pharmaceuticals, the parent company of Prescriber’s Choice and Sincerus Florida, today announced the completion of a major new round of growth financing with SWK Holdings Corporation (Nasdaq: SWKH), representing what is by far…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.